Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 1,480 | 217 | 216 | 521 | 287 |
| Operating Income | -1,480 | -217 | -216 | -521 | -287 |
| Interest Expense | 85 | 62 | 59 | 67 | 70 |
| Other Income | 6 | 9 | 33 | -36 | -59 |
| Pre-tax Income | -1,559 | -270 | -242 | -624 | -416 |
| Net Income Continuous | -1,559 | -270 | -242 | -624 | -416 |
| Net Income | $-1,559 | $-270 | $-242 | $-624 | $-416 |
| EPS Basic Total Ops | -0.02 | -0.02 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.02 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-1,474 | $-207 | $-183 | $-558 | $-346 |